MedTrace Logo

Methodological Validation of Ibuprofen Verses Placebo for Post Operative Pain After Third Molar Extraction Surgery

NCT02096926 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2015-04-08

No results posted yet for this study

Summary

This is a single center placebo controlled, prospective, randomized study on healthy adults undergoing third molar surgery.

Conditions

  • Dental Pain

Interventions

DRUG

Placebo

DRUG

Ibuprofen

400 mg PO

Sponsors & Collaborators

  • Lotus Clinical Research, LLC

    lead OTHER

Principal Investigators

  • Sonia Singla, DO · Lotus Clinical Research, LLC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2014-05-31
Completion
2014-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02096926 on ClinicalTrials.gov